3 completed, 1 unknown, 1 withdrawn. 5 Phase 2, 2 Phase 1, 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 5 | Completed 3, Unknown 1, Withdrawn 1 |
| Phase 1 | 2 | Completed 1, Unknown 1 |
| Phase 3 | 1 | Completed 1 |
Follow Posterior Uveitis: new trials by email Literature Review of Posterior Uveitis trials Research Report on Posterior Uveitis
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Intravitreal Sirolimus as Therapeutic Approach to Uveitis Intravitreal injection 440mcg, Intravitreal injection of sirolimus 880mcg - Uveitis, Intermediate Uveitis | Phase 2 | Withdrawn | Stanford University | 2022-09-01 | 2023-10-26 | |
| Study of the Safety, Tolerability, and Bioactivity of Tocilizumab On Patients With Non-infectious UVEITIS: The STOP-UVEITIS Study Tocilizumab - Intermediate Uveitis, Posterior Uveitis | Phase 1 / Phase 2 | Unknown | University of Nebraska | 36 | 2013-03-01 | 2017-04-28 |
| Safety Study of Suprachoroidal Triamcinolone Acetonide Via Microneedle to Treat Uveitis triamcinolone acetonide (Triesence®) - Uveitis, Intermediate Uveitis | Phase 1 / Phase 2 | Completed | Clearside Biomedical, Inc. | 11 | 2013-02-01 | 2021-02-21 |
| Safety, Tolerability, and Efficacy of AEB071 in the Treatment of Uveitis AEB071 - Uveitis, Posterior Uveitis | Phase 2 | Completed | Novartis | 13 | 2008-07-01 | 2020-12-22 |
| A Study of the Safety and Efficacy of a New Treatment for Non-Infectious Intermediate or Posterior Uveitis Dexamethasone, dexamethasone, Sham injection - Intermediate Uveitis, Posterior Uveitis | Phase 2 / Phase 3 | Completed | Allergan | 229 | 2006-05-01 | 2011-04-14 |
Uveitis, Posterior (5) · Uveitis, Intermediate (4) · Panuveitis (3) · Uveitis (3) · Choroidal Effusions (1) · Giant Cell Arteritis (1) · Inflammation (1) · Macular Edema (1) · Ophthalmia, Sympathetic (1)
Eye Diseases (5) · Uveal Diseases (5) · Panuveitis (2) · Uveitis (2) · Arteritis (1) · Autoimmune Diseases (1) · Autoimmune Diseases of the Nervous System (1) · Brain Diseases (1) · Cardiovascular Diseases (1) · Central Nervous System Diseases (1) · Cerebrovascular Disorders (1) · Choroid Diseases (1) · Eye Abnormalities (1) · Immune System Diseases (1) · Macular Degeneration (1)
Adrenal Cortex Hormones (1) · Contraceptives, Oral (1) · Dexamethasone (1) · Intravitreal Injections (1) · Triamcinolone (1) · Triamcinolone Acetonide (1) · salicylhydroxamic acid (1) · sotrastaurin (1) · tocilizumab (1)
Allergan (1) · Clearside Biomedical, Inc. (1) · Novartis (1) · Stanford University (1) · University of Nebraska (1)
United States (5) · Australia (1) · Austria (1) · Brazil (1) · Canada (1) · Czechia (1) · France (1) · Germany (1) · Greece (1) · India (1) · Israel (1) · Poland (1) · Portugal (1) · South Africa (1) · South Korea (1)
Quan D Nguyen, MD, MSc (2) · Thomas Ciulla, MD (1)
PMID 21220619, PMID 23411886, PMID 23761087, PMID 27980877, PMID 33042579, PMID 37172782